| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |